Question 1

What is BDX stock price today?

Accepted Answer

Becton, Dickinson and Company (BDX) is currently trading at $158.08, up 3.39% today.

Question 2

What is BDX market cap?

Accepted Answer

Becton, Dickinson and Company has a market capitalization of $55 billion, making it one of the notable companies in the Healthcare sector.

Question 3

What is BDX P/E ratio?

Accepted Answer

Becton, Dickinson and Company has a P/E ratio of 40.02, which measures the stock price relative to its earnings per share.

Question 4

What is BDX price target?

Accepted Answer

The average analyst price target for Becton, Dickinson and Company is $176.25, which represents a 11.5% upside from the current price.

Question 5

What is BDX 52-week high and low?

Accepted Answer

Becton, Dickinson and Company's 52-week high is $187.35 and 52-week low is $127.59. The current price of $158.08 is 51% of its 52-week range.

Question 6

What do analysts say about BDX?

Accepted Answer

Analysts currently rate Becton, Dickinson and Company as Hold. Coverage is updated daily from major firms.

Question 7

Does BDX pay a dividend?

Accepted Answer

Yes, Becton, Dickinson and Company (BDX) pays a dividend with a current yield of 2.45%. This means for every $1,000 invested, you would receive approximately $24.48 per year in dividends.

Question 8

Is BDX revenue growing?

Accepted Answer

Becton, Dickinson and Company has a year-over-year revenue growth rate of -10.6%. Revenue has declined compared to the prior year.

Question 9

What sector is BDX in?

Accepted Answer

Becton, Dickinson and Company (BDX) operates in the Healthcare sector within the Medical - Instruments & Supplies industry. You can explore other stocks in this sector on our Healthcare sector page.

Question 10

How has BDX performed this year?

Accepted Answer

Becton, Dickinson and Company (BDX) has a year-to-date return of +0.2%. The stock has had a positive year so far.

Question 11

Is BDX overvalued or undervalued?

Accepted Answer

Becton, Dickinson and Company has a forward P/E ratio of 11.8 compared to its trailing P/E of 40.0. A lower forward P/E suggests analysts expect earnings growth. Visit the BDX stock page for detailed valuation analysis.

Becton, Dickinson and Company

Price chart

Price performance

The thesis at a glance

Who's buying BDX right now

Latest print - beat on both lines

11 analysts · 45% Buy

How BDX stacks vs Medical - Instruments & Supplies

Peers & themes